Investing in tomorrow's medicine
Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.
MERIEUX EQUITY PARTNERS ACQUIRES MAJORITY STAKE IN PLANTEX, VIA ITS MERIEUX PARTICIPATIONS 3 VEHICLE
Plantex is a French manufacturer of high quality natural plant extracts for nutraceutical, dietary, animal nutritional and cosmetic purposes.
Merieux Equity Partners invests in Laboratoires CTRS alongside the Management Team, via its Merieux Participations 3 vehicle.
CTRS is a French pharmaceutical company that develops and markets treatments for patients with strong unmet medical needs, with a particular focus on orphan diseases.
Cell-Easy announces the completion of a financing round to accelerate its growth trajectory in the cell therapy sector, with Merieux Equity Partners as lead investor and reference shareholder
Cell-Easy is a stem cell Contract Development and Manufacturing Organization (CDMO) that provides ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development.